Money
Temasek’s S$30b deals: From tire makers to pharma firms
Temaseku00e2u20acu2122s Head of Strategy Michael Buchanan gives a presentation during the annual Temasek Review in Singapore July 7, 2016. u00e2u20acu201d Reuters pic

SINGAPORE, July 7 — Temasek Holdings Pte disclosed that it made S$30 billion (RM89.4 billion) in new investments in the 12 months through March, matching the previous year’s pace, while divesting of a record S$28 billion as it re-balances its portfolio. Here are some of the investments made by Singapore’s state firm during the period:

*Increased position in US logistics sector: US$450 million (RM1.8 billion) investment in Univar Inc, a distributor of commodity and specialty chemicals.

*Added to biotechnology: investments in Alexion Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc, companies that develop transformative treatments for serious diseases.

*In China, which accounts for the largest share of investments in Asia, invested in Zhongce Rubber Group Co, a domestic tire manufacturer; Cainiao Network Technology Co, a data and technology-based logistics platform focused on e-commerce; increased stake in Industrial and Commercial Bank of China; invested in Postal Savings Bank of China Co, a provider of financial services to rural, small-to-medium enterprises, and to retail banking segments.

*In South Korea, invested in Homeplus Co, a domestic hypermarket operator with 140 stores.

*In India, invested in Glenmark Pharmaceuticals Ltd, a global manufacturer and distributor of branded and generic pharmaceuticals; ICICI Prudential Life Insurance Co, a life insurance company; and CarTrade, an online auto classifieds company.

*In Europe, invested CHF600 million (RM2.4 billion) in Switzerland-based international airport retail operator, Dufry AG, to help finance its merger with World Duty Free to create one of the largest travel retailers worldwide. Also acquired a stake in Blue Fin Building, a Grade A property located in South Bank, London.

*Among financial services, expanded further into non-banking sub-sectors including an investment in PayPal Holdings Inc, a digital payment service provider operating in more than 200 markets worldwide; invested in smaller but fast-growing technology-enabled companies, such as SoFi and C2FO in the US, Funding Circle in the UK, and BillDesk and Policy Bazaar in India.

*In investment brokerage, invested about HK$2 billion (RM1.03 billion) in CITIC Securities, a full-service securities firm in China.

*Technology/sharing economy investments include Airbnb Inc, a global marketplace for travel accommodation in 190 countries worldwide; and increased investment in Didi Chuxing, a Chinese transportation network company; Meituan-Dianping, an online-to-offline local service platform in China.

*In October 2015, committed to funding Dell Inc’s merger with EMC Corp.

*Among life sciences and agriculture companies, invested in WuXi PharmaTech, a global provider of laboratory and manufacturing services to biopharma and medical device companies; Alvogen Pharma US Inc, an international generics pharmaceuticals company; increased stake in COFCO International Ltd., a holding company which owns the controlling stakes in international supply chain managers Nidera and Noble Agri, in conjunction with its buyout of the remaining Noble Agri minority stake. — Bloomberg

Related Articles

 

You May Also Like